Ozempic Is Just the Beginning: What’s Next in Weight Loss Drugs | Dr Spencer Nadolsky | Dr Karan
Dr. Karan Rajan — Ozempic Is Just the Beginning: What’s Next in Weight Loss Drugs | Dr Spencer Nadolsky | Dr Karan
Channel: Dr Karan · Our label: Physician educator (NHS) — myth-busting voice · Source: youtube.com/watch?v=2X_-6R_86z4
What this video covers
Do you think over the next decade, two decades, these weight loss injections and their spin-offs will completely eliminate the need for surgical intervention? » We’re already seeing a very large decline in surgery. 10 years from now, 20 years from now, I think it will put it extinct. » I had an interesting conversation on this podcast a few months back with Dr.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Whether you’re here in the States, FDA, or in Europe, there’s a lot of people taking them for micro doing purposes for in inflammation.
- And a lot of these people are using unapproved uh compounded versions that haven’t been studied that we don’t know if they might be fine, but they might not be fine.
- GLP1 agonist is what everyone understands, but we’ve got GLP-1 GIP agonist and more drugs in the future which target other appetite hormones and receptors.
- And if they didn’t tolerate it, you know, and they had to leave the the the trial, they they left the trial.
- They have to for, you know, a certain health outcome to improve their health.
- I mean for anybody listening the GLP1 gets broken down our natural GLP-1 is is released from our intestines after we eat food carbohydrate containing foods broken down very quickly within 1 to 2 minutes.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.